New biomarker paves the way for a clinical trial for neurodegeneration in Langerhans cell histiocytosis
Sign Up to like & getrecommendations! Published in 2022 at "British Journal of Haematology"
DOI: 10.1111/bjh.18308
Abstract: Neurodegeneration in Langerhans cell histiocytosis (ND‐LCH) is a major clinical issue requiring urgent resolution. Sveijer et al. showed that plasma neurofilament light protein is a promising biomarker for screening patients with ND‐LCH and determining the… read more here.
Keywords: neurodegeneration langerhans; cell histiocytosis; langerhans cell; new biomarker ... See more keywords